SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K/A - Report of foreign issuer [Rules 13a-16 and 15d-16]: [Amend]
SEC Accession No. 0001213900-24-050777
Filing Date
2024-06-07
Accepted
2024-06-07 16:15:12
Documents
7
Period of Report
2024-06-07

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 6-K ea0206358-6ka1_canfite.htm 6-K/A 17100
2 NOTICE AND PROXY STATEMENT WITH RESPECT TO THE COMPANY'S ANNUAL GENERAL MEETING ea020635802ex99-1_canfite.htm EX-99.1 99074
3 PROXY CARD FOR HOLDERS OF ORDINARY SHARES WITH RESPECT TO THE COMPANY'S ANNUAL G ea020635802ex99-2_canfite.htm EX-99.2 27743
4 VOTING INSTRUCTION CARD FOR AMERICAN DEPOSITARY SHAREHOLDERS WITH RESPECT TO THE ea020635802ex99-3_canfite.htm EX-99.3 1559
5 GRAPHIC ex99-1_001.jpg GRAPHIC 10582
6 GRAPHIC ex99-3_001.jpg GRAPHIC 745421
7 GRAPHIC ex99-3_002.jpg GRAPHIC 525218
  Complete submission text file 0001213900-24-050777.txt   1910399
Mailing Address 26 BEN GURION STREET RAMAT GAN L3 5257346
Business Address 26 BEN GURION STREET RAMAT GAN L3 5257346 972 39241114
Can-Fite BioPharma Ltd. (Filer) CIK: 0001536196 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K/A | Act: 34 | File No.: 001-36203 | Film No.: 241029595
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)